Punctal Atresia as a Clinical Indicator of Systemic Genetic Anomalies
Author: Daphna Landau
Base Hospital / Institution: Children’s Hospital of Philadelphia (Research Affiliate); Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel (Consultant, Oculofacial, lacrimal and orbital surgery)
Rapid fire oral presentation
Abstract ID: 24-158
Purpose
Punctal atresia or agenesis (PA) is a rare congenital anomaly characterized by the absence or closure of the tear duct puncta, potentially linked to systemic genetic anomalies. The necessity of a genetic workup based solely on the presence of PA remains uncertain. This study investigates a cohort of PA patients, examining the prevalence and types of associated syndromes.
Methods
A retrospective medical records review of all patients diagnosed with PA at the Children’s Hospital of Philadelphia between 2009-2023 was conducted, analyzing medical histories and genetic testing results. Primary outcomes included the prevalence of systemic syndromes, while secondary outcomes focused on the variety of associated syndromes.
Results
Forty-four patients were included, of which 31 were male (70%) with a mean±SD age 3.3±3.3 years. Overall, 87 puncta in the study cohort were affected, and 26 cases (59%) were bilateral. Systemic abnormalities or genetic syndromes were identified in 19 patients (43%), with the most common being Ectodermal Dysplasia and Down syndrome. Additional rare syndromes were demonstrated. No significant association was found between systemic abnormalities and gender, bilaterality, or the number of puncta involved.
Conclusion
The study indicates a high incidence of systemic syndromes in patients with PA, suggesting that PA should be an indication for systemic evaluation with consideration of genetic testing. Syndromic diagnoses identified in our cohort also include: Branchio-oto-renal syndrome, 22q11.2 deletion syndrome, 1q21.1 microdeletion syndrome, NF1, monosomy 4q and trisomy 6q, which represent novel associations. The lack of correlation between PA’s phenotypic severity and systemic abnormalities highlights the need for a comprehensive systemic workup in all PA patients.
Additional Authors
| First name | Last name | Base Hospital / Institution |
|---|---|---|
| Rayna | Marshall | Children’s Hospital of Philadelphia (Research Affiliate); Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel (Consultant, Oculofacial, lacrimal and orbital surgery) |
| Alanna | Strong | Children’s Hospital of Philadelphia (Research Affiliate); Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel (Consultant, Oculofacial, lacrimal and orbital surgery) |
| James A. | Katowitz | Children’s Hospital of Philadelphia (Research Affiliate); Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel (Consultant, Oculofacial, lacrimal and orbital surgery) |
| William R | Katowitz | Children’s Hospital of Philadelphia (Research Affiliate); Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel (Consultant, Oculofacial, lacrimal and orbital surgery) |

